Morabito Quoted in The Wall Street Journal about Court Approval of GST AutoLeather Bankruptcy Sale
13 November 2017
Partner Erika Morabito is quoted in a Wall Street Journal article, “GST AutoLeather Wins Court Approval of Bankruptcy Sale Process,” about an agreement between the company’s lenders and unsecured creditors on financing, fees and a process to sell the bankrupt upholstery maker’s business.
Morabito, counsel to the company’s official committee of unsecured creditors, said during a bankruptcy hearing that the lenders were holding the process “hostage” and called “insulting” a court filing by Royal Bank of Canada, part of a group of lenders, that said the unsecured creditors “should be cheering” the financing, “not objecting” to it.
Click here to read the full article (subscription required).
Morabito, counsel to the company’s official committee of unsecured creditors, said during a bankruptcy hearing that the lenders were holding the process “hostage” and called “insulting” a court filing by Royal Bank of Canada, part of a group of lenders, that said the unsecured creditors “should be cheering” the financing, “not objecting” to it.
Click here to read the full article (subscription required).
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”